Triall featured in Applied Clinical Trials.
07 Feb 2023, 13:14
Triall featured in Applied Clinical Trials šļø
Our CEO Hadil Es-Sbai has written an article for Applied Clinical Trials (@Clin_Trials).
The article explains how Self-Sovereign Identity (#SSI) and #blockchain can enable patient data ownership.
š Link:
Same news in other sources
2
07 Feb 2023, 13:16
Triall featured in Applied Clinical Trials šļø
Triall CEO Hadil Es-Sbai authored an article for Applied Clinical Trials Magazine, one of the top journals for clinical operations professionals.
The article covers the current state of patient-centric clinical research, focusing on the areas of convenience, empowerment, and privacy.
It then takes a leap forward by examining how Self-Sovereign Identity (SSI), a novel approach to digital identity and access management, will help advance patient-centric research by enabling patient data ownership.
š Article link:
ā”ļø Trade $TRL at bit.ly/tradeTRL
š£ Help us spread the news on Twitter:
#blockchainforhealth #TRL
Triall featured in Applied Clinical Trials.
Triall featured in Applied Clinical Trials šļø
Triall CEO Hadil Es-Sbai authored an article for Applied Clinical Trials Magazine, one of the top journals for clinical operations professionals.
The article covers the current state of patient-centric clinical research, focusing on the areas of convenience, empowerment, and privacy.
It then takes a leap forward by examining how Self-Sovereign Identity (SSI), a novel approach to digital identity and access management, will help advance patient-centric research by enabling patient data ownership.
š Article link: https://www.appliedclinicaltrialsonline.com/view/enabling-patient-data-ownership-with-self-sovereign-identity
ā”ļø Trade $TRL at bit.ly/tradeTRL
š£ Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1622946925786943488?s=20&t=Pg_M83QhNwRGT1HpituF3w
#blockchainforhealth #TRL
07 Feb 2023, 13:16
Triall featured in Applied Clinical Trials šļø
Triall CEO Hadil Es-Sbai authored an article for Applied Clinical Trials Magazine, one of the top journals for clinical operations professionals.
The article covers the current state of patient-centric clinical research, focusing on the areas of convenience, empowerment, and privacy.
It then takes a leap forward by examining how Self-Sovereign Identity (SSI), a novel approach to digital identity and access management, will help advance patient-centric research by enabling patient data ownership.
š Article link:
ā”ļø Trade $TRL at bit.ly/tradeTRL
š£ Help us spread the news on Twitter:
#blockchainforhealth #TRL
Triall featured in Applied Clinical Trials.
Triall featured in Applied Clinical Trials šļø
Triall CEO Hadil Es-Sbai authored an article for Applied Clinical Trials Magazine, one of the top journals for clinical operations professionals.
The article covers the current state of patient-centric clinical research, focusing on the areas of convenience, empowerment, and privacy.
It then takes a leap forward by examining how Self-Sovereign Identity (SSI), a novel approach to digital identity and access management, will help advance patient-centric research by enabling patient data ownership.
š Article link: https://www.appliedclinicaltrialsonline.com/view/enabling-patient-data-ownership-with-self-sovereign-identity
ā”ļø Trade $TRL at bit.ly/tradeTRL
š£ Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1622946925786943488?s=20&t=Pg_M83QhNwRGT1HpituF3w
#blockchainforhealth #TRL